Thrombotic manifestations of antiphospholipid syndrome are often a therapeutic dilemma
and challenge. Despite our increasing knowledge of this relatively new disease, many …

Persistence of serum antiphospholipid antibodies (aPL) is associated with a high thrombotic
risk, both arterial and venous, and with pregnancy complications. Due to the potential …

Objectives Thrombocytopenia, a frequent clinical manifestation in patients with APS, could
be an independent predictor of recurrent thrombotic, obstetric and severe extracriteria …

Abstract The adjusted Global Antiphospholipid Syndrome (APS) Score (aGAPSS) is a tool
proposed to quantify the risk for antiphospholipid antibody (aPL)-related clinical …

The central nervous system (CNS) is considered as one of the most frequently affected
organs in antiphospholipid syndrome (APS). This study investigated the prevalence of CNS …

Introduction Antiphospholipid syndrome (APS) is an autoimmune disorder associated with
thrombosis and adverse obstetric outcomes. Early diagnosis and intervention can improve …

Stroke is considered one of the most common and life-threatening manifestations of
antiphospholipid syndrome (APS), which leads to high mortality and permanent disability …

The aim of this study was to investigate the subsequent early pregnancy outcomes in
women positive for non-criteria antiphospholipid antibodies (NC-aPLs) before pregnancy. A …

Objective. We aimed to identify features that allow differentiation of primary antiphospholipid
syndrome (PAPS) patients that suffer recurrent thrombotic events (RTE) despite …

Background Observational studies suggest a connection between autoimmune diseases
(AD) and attention deficit hyperactivity disorder (ADHD). Nevertheless, the causality …